Newer evidence from the POP-RT phase III trial did show that pelvic nodal radiation for high-risk, locally advanced prostate ...

Now that Prostate Cancer Awareness Month has ended, Mercy Health is urging men to take a closer look at what they really know ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.

OU Health Stephenson Cancer Center is raising awareness of prostate cancer.

The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study ...

Eric Morrow had a family history of prostate cancer, but because he was not yet 55, they wouldn't screen him. However, a ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

Nearly half of patients with metastatic castration-resistant prostate cancer harboring BRCA1/2 alterations do not receive PARP inhibitors, a new study finds.

SGMC Health now offers PLUVICTO, a cutting-edge therapy for men diagnosed with metastatic castration-resistant prostate ...

The importance of all health screenings is that they can detect issues early. Prostate cancer is one of the most common ...